Brenus adds €11M to colorectal cancer vaccine development...

Brenus Pharma

AMBER Tx General

Strategy Notes

Keyword match: +3 relevant, -0 negative signals.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: €11M
Type: funding
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-28 OPEN → INELIGIBLE · The programme is a Series A extension funding round for a French biotech company (Brenus Pharma) developing a colorectal cancer vaccine. It is not a grant, fellowship, or open application programme; it is a private investment round for an existing company. The applicant is an independent researcher with no company or institutional affiliation that matches the funding vehicle.